Precigen, Inc. (PGEN) vs TransMedics Group, Inc. (TMDX)
A side-by-side comparison of Precigen, Inc. and TransMedics Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PGEN
Precigen, Inc.
$7.63HealthcareDelayed quote: Oct 6, 2026, 3:10 PM EDT
TMDX
TransMedics Group, Inc.
$80.90HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — PGEN vs TMDX
growth of $100 · dividends reinvested · last 7yPGEN +78.8% (+8.7%/yr)TMDX +271.2% (+20.6%/yr)TMDX compounded faster over this window
PGEN TMDX
PGEN vs TMDX: by the numbers
- •TMDX is the larger company ($2.80B vs $2.72B market cap).
- •TMDX is profitable (22.69% net margin) while PGEN runs a net loss (-183.98%).
- •TMDX grew revenue faster over the past five years (86.12% vs -21.26% CAGR).
Metrics side by side
Valuation
| Metric | PGEN | TMDX |
|---|---|---|
| P/E ratio | N/A | 20.96 |
| Forward P/E | 44.51 | 55.15 |
| P/S ratio | 31.73 | 4.18 |
| P/B ratio | 62.41 | 5.40 |
| EV / EBITDA | N/A | 27.04 |
| FCF yield | N/A | 2.83% |
Profitability
| Metric | PGEN | TMDX |
|---|---|---|
| Gross margin | 37.05% | 58.69% |
| Operating margin | -1100.78% | 12.21% |
| Net margin | -183.98% | 22.69% |
| ROE | -361.91% | 29.28% |
| ROIC | -28.02% | 5.87% |
Growth (annualized)
| Metric | PGEN | TMDX |
|---|---|---|
| Revenue CAGR (5Y) | -21.26% | 86.12% |
| Total return CAGR (5Y) | 8.79% | 21.77% |
Frequently asked
- Which has grown faster, PGEN or TMDX?
- Over the past five years, TMDX grew revenue faster — PGEN at a -21.26% CAGR versus TMDX at 86.12%.
- Is PGEN or TMDX more profitable?
- TMDX runs the higher net margin — PGEN at -183.98% versus TMDX at 22.69%.
- How have PGEN and TMDX total returns compared?
- Over the past 5 years, PGEN delivered 8.79% and TMDX delivered 21.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
TransMedics P/E ratioPrecigen ROETransMedics ROEPrecigen operating marginTransMedics operating marginPrecigen revenue growthTransMedics revenue growthPrecigen free cash flowTransMedics free cash flow
Precigen & TransMedics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.